PlainRecalls
FDA Drug Moderate Class II Terminated

MYORISAN (isotretinoin capsules, USP), 20mg, packaged in 30-count Capsules (3 x 10 Prescription Packs) per box, Rx only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forset, IL 60045; NDC 61748-302-13.

Reported: January 8, 2020 Initiated: November 15, 2019 #D-0647-2020

Product Description

MYORISAN (isotretinoin capsules, USP), 20mg, packaged in 30-count Capsules (3 x 10 Prescription Packs) per box, Rx only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forset, IL 60045; NDC 61748-302-13.

Reason for Recall

Unit Dose Mispackaging: Customer complaint that a carton labeled as Myorisan 20 mg Capsules, USP erroneously contained one 10-count blister card of the 40 mg product in addition to two 10-count blister cards of the 20 mg product.

Details

Recalling Firm
Akorn, Inc.
Units Affected
4,206 boxes
Distribution
Nationwide in the USA and Puerto Rico
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
MYORISAN (isotretinoin capsules, USP), 20mg, packaged in 30-count Capsules (3 x 10 Prescription Packs) per box, Rx only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forset, IL 60045; NDC 61748-302-13.. Recalled by Akorn, Inc.. Units affected: 4,206 boxes.
Why was this product recalled?
Unit Dose Mispackaging: Customer complaint that a carton labeled as Myorisan 20 mg Capsules, USP erroneously contained one 10-count blister card of the 40 mg product in addition to two 10-count blister cards of the 20 mg product.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 8, 2020. Severity: Moderate. Recall number: D-0647-2020.